Package 25021-259-51

{"route": ["INTRAVENOUS"], "spl_id": "c956537f-71c0-44bc-a2e2-ab2adaa4f756", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["f60da70f-2f9e-421d-a277-95b1edb57a71"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-259-50)  / 50 mL in 1 VIAL", "package_ndc": "25021-259-50", "marketing_start_date": "20240801"}, {"sample": false, "description": "6 VIAL in 1 CARTON (25021-259-51)  / 50 mL in 1 VIAL", "package_ndc": "25021-259-51", "marketing_start_date": "20240801"}], "brand_name": "Nelarabine", "product_id": "25021-259_c956537f-71c0-44bc-a2e2-ab2adaa4f756", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-259", "generic_name": "Nelarabine", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA212605", "marketing_category": "ANDA", "marketing_start_date": "20240801", "listing_expiration_date": "20261231"}